LNP200 NVR Pill - yellow capsule/oblong
Generic Name: iptacopan
Pill with imprint LNP200 NVR is Yellow, Capsule/Oblong and has been identified as Fabhalta 200 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Fabhalta is used in the treatment of C3 Glomerulopathy; Immunoglobulin A Nephropathy; Paroxysmal Nocturnal Hemoglobinuria and belongs to the drug class selective immunosuppressants. Fabhalta 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LNP200 NVR
Fabhalta
- Generic Name
- iptacopan
- Imprint
- LNP200 NVR
- Strength
- 200 mg
- Color
- Yellow
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-1189
See also:
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Filspari
Filspari is used for primary immunoglobulin A nephropathy (IgAN), to slow kidney function decline ...
Empaveli
Empaveli (pegcetacoplan) is an immunosuppressant that is given by subcutaneous (under the skin) ...
Soliris
Soliris infusion is used to treat paroxysmal nocturnal hemoglobinuria (PNH) or neuromyelitis optica ...
Voydeya
Voydeya (danicopan) is an oral complement factor D inhibitor that may be used to treat ...
Epysqli
Epysqli (eculizumab-aagh), a biosimilar to Soliris, targets the complement system to treat ...
PiaSky
PiaSky (crovalimab-akkz) may be used to treat paroxysmal nocturnal hemoglobinuria (PNH) in adults ...
Pegcetacoplan
Pegcetacoplan (brand name Empaveli) is a twice-weekly, injectable medicine that may be used to ...
Ravulizumab
Ravulizumab-cwvz is used to treat myasthenia gravis (gMG), hemolytic uremic syndrome (aHUS) ...
More about Fabhalta (iptacopan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.